Jasper Therapeutics Highlights Recent Accomplishments and Ke

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively

Related Keywords

United States , America , Joyce Allaire , Patricia Carlos , Lauren Barbiero , Edwinj Tucker , Scott Brun , Alex Gray , Ronald Martell , European Union Orphan Drug Designation , Regulatory Affairs Quality , European Medicines Agency , America Society Of Hematology , Nasdaq , Company Clinical Trial Applications , Jasper Therapeutics Inc , Clinical Trial Applications , Chief Executive Officer , Fanconi Anemia , America Society , Thomas Wiggans , Herb Cross , Chief Financial Officer , Chief Medical Officer , Regulatory Affairs , Annual Report , Quarterly Reports , Region ,